3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Sleep Initiation and Maintenance Disorders
1
Pain
1
Ovarian Neoplasms
1
Neuropathy, Painful
1
Neuralgia
1
Hematologic Neoplasms
1
Glioma
1
Chronic Pain
1
Cervical Adenocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage I Breast Cancer AJCC v8
1
Agnosia
1
Interventions
Acetaminophen
4
Surveys and Questionnaires
3
Saline Solution
3
nabiximols
2
Standard of Care
2
Radiofrequency Ablation
2
Oxycodone
2
Music Therapy
2
Morphine
2
Methods
2
Electroacupuncture
2
Dronabinol
2
siltuximab
1
pegfilgrastim
1
oxycodone-acetaminophen
1
erenumab
1
Yoga
1
Xylitol
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Direct Current Stimulation
1
Therapeutics
1
Telemedicine
1
STAMP-I protocol
1
Remifentanil
1
Range of Motion, Articular
1
Psychiatric Rehabilitation
1
Preoperative Exercise
1
Physical Therapy Modalities
1
Pentoxifylline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Yoga
×
1 year
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled